Outcome of allogeneic haematopoietic stem cell transplant for philadelphia chromosome positive acute lymphoblastic leukaemia in paediatric patients in the era of tyrosine kinase inhibitors and strategies for management of relapse: a UK multicentre study

被引：0
|
作者：
Furness, C. L. [1 ]
Ethell, M. E. [1 ]
Saha, V. [2 ]
Parker, C. [2 ]
Vora, A. J. [3 ]
Skinner, R. [4 ]
Amrolia, P. J. [5 ]
Veys, P. [5 ]
Lawson, S. [6 ]
Potter, M. N. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Haematooncol, Sutton, Surrey, England
[2] Manchester Acad Hlth Sci Ctr, Childrens Canc Grp, Ctr Paediat Teenage & Young Adult Canc, Inst Canc, Manchester, Lancs, England
[3] Sheffield Childrens Hosp, Dept Paediat Hematol, Sheffield, S Yorkshire, England
[4] Royal Victoria Infirm, Dept Paediat Oncol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[5] Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplant, London WC1N 3JH, England
[6] Birmingham Childrens Hosp, Dept Paediat Haematol, Birmingham, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [41] IMPACT OF ALLOGENEIC STEM CELL TRANSPLANTATION ON TYROSINE KINASE DOMAIN MUTATIONS AND MINIMAL RESIDUAL DISEASE LEVELS IN PATIENTS WITH PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Pfeifer, H.
    Wystub, S.
    Schmidt-Tanguy, A.
    Stadler, M.
    Dengler, J.
    Bethge, W.
    Lange, T.
    Meyer, J.
    Platzbecker, U.
    Wassmann, B.
    Brueck, P.
    Goekbuget, N.
    Serve, H.
    Hoelzer, D.
    Ottmann, O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 250 - 250
  • [42] The effect of different types of allogeneic hematopoietic stem cell transplantation donors in Philadelphia chromosome-positive acute lymphoblastic leukemia during tyrosine kinase inhibitors era: A systematic review and meta-analysis.
    Ponvilawan, Ben
    Kungwankiattichai, Smith
    Charoenngam, Nipith
    Owattanapanich, Weerapat
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lyu, Mengnan
    Jiang, Erlie
    He, Yi
    Yang, Donglin
    Ma, Qiaoling
    Pang, Aiming
    Zhai, Weihua
    Wei, Jialin
    Huang, Yong
    Zhang, Guixin
    Zhang, Rongli
    Feng, Sizhou
    Han, Mingzhe
    HEMATOLOGY, 2021, 26 (01) : 65 - 74
  • [44] High efficacy of dasatinib in maintenance therapy after allogeneic haematopoietic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Czyz, A.
    Czerw, T.
    Nasilowska-Adamska, B.
    Dybko, J.
    Kata, D.
    Dutka, M.
    Pogorzala, M.
    Basak, G.
    Mensah-Glanowska, P.
    Gora-Tybor, J.
    Gniot, M.
    Lewandowski, K.
    Giebel, S.
    Halaburda, K.
    Kyrcz-Krzemien, S.
    Komarnicki, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S270 - S271
  • [45] Improving results of autologous stem cell transplantation for Philadelphia-positive acute lymphoblastic leukaemia in the era of tyrosine kinase inhibitors: A report from the Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation
    Giebel, Sebastian
    Labopin, Myriam
    Gorin, Norbert Claude
    Caillot, Denis
    Leguay, Thibaut
    Schaap, Nicolaas
    Michallet, Mauricette
    Dombret, Herve
    Mohty, Mohamad
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (02) : 411 - 417
  • [46] Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant
    Kim, Kunhwa
    Jabbour, Elias
    Short, Nicholas J.
    Kebriaei, Partow
    Kantarjian, Hagop
    Ravandi, Farhad
    CURRENT ONCOLOGY REPORTS, 2021, 23 (08)
  • [47] Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes
    Kebriaei, Partow
    Saliba, Rima
    Rondon, Gabriela
    Chiattone, Alexandre
    Luthra, Rajyalakshmi
    Anderlini, Paolo
    Andersson, Borje
    Shpall, Elizabeth
    Popat, Uday
    Jones, Roy
    Worth, Laura
    Ravandi, Farhad
    Thomas, Deborah
    O'Brien, Susan
    Kantarjian, Hagop
    de Lima, Marcos
    Giralt, Sergio
    Champlin, Richard
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (04) : 584 - 592
  • [48] Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Gebel, Sebastian
    Czyz, Anna
    Ottmann, Oliver
    Baron, Frederic
    Brissot, Eolia
    Ciceri, Fabio
    Cornelissen, Jan J.
    Esteve, Jordi
    Gorin, Norbert-Claude
    Savani, Bipin
    Schmid, Christoph
    Mohty, Mohamed
    Nagler, Arnon
    CANCER, 2016, 122 (19) : 2941 - 2951
  • [49] Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia
    Ozawa, Y.
    Nishiwaki, S.
    Koyama, D.
    Onodera, K.
    Goto, T.
    Seto, A.
    Watanabe, K.
    Imahashi, N.
    Tsukamoto, S.
    Miyamura, K.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S293 - S294
  • [50] Administration of tyrosine-kinase inhibitors in patients with Ph(+) leukaemias who relapse after allogeneic haematopoietic stem cell transplantation
    Batsis, I.
    Baliakas, P.
    Marvaki, N.
    Mallouri, D.
    Touloumenidou, T.
    Kaloyannidis, P.
    Yannaki, E.
    Sakellari, I.
    Anagnostopoulos, A.
    Papanikolaou, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S259 - S260
12345